Berry Genomics Completes $619M Back-Door Listing In Shenzhen
August 30, 2017 — 12:07 CST
This Data Is Locked!
This area is available only to Subscribers.
Berry Genomics, a Chinese prenatal genetic testing and diagnostics company backed by Qiming Venture Partners and Legend Capital, has completed a reverse merger with Shenzhen-listed... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals